Jazz Pharmaceuticals Receives Approval for the Use of Epidyolex in the UK Leave a comment
The UK Medicines and Healthcare Products Regulatory Agency (MHRA) has approved the use of Epidyolex to be used for seizures related to tuberous sclerosis complex (TSC).
